EA
EXAS

Emerald Acquisition’s Exact Sciences EXAS Stock Holding History

Emerald Acquisition’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$184K Buy
+9,898
New +$174K ﹤0.01% 2708

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Acquisition's EXAS Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Exact Sciences (EXAS) in Q3 2016: 9,898 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #2708 among its holdings.

224 funds tracked by Wall St. Rank hold EXAS as of Q3 2016.

  • Emerald Acquisition held 9,898 shares of Exact Sciences worth $184K as of Q3 2016.
  • Exact Sciences was a new Emerald Acquisition position in Q3 2016.
  • Exact Sciences made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2708 holding.
  • 224 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.